콘텐츠로 건너뛰기
주식/증권 📈 긍정적

RVTY Expands Endocrine Diagnostics With FDA-Cleared Testosterone Assay

요약

Revvity gains FDA clearance for IDS' Total Testosterone assay, expanding its automated endocrine testing platform for reproductive diagnostics.